NCT01677559View on ClinicalTrials.gov

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 7, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

August 11, 2017

Conditions
AdenocarcinomaPancreatic Neoplasms
Interventions
DRUG

MLN8237

DRUG

nab-Paclitaxel

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01677559 - Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies | Biotech Hunter | Biotech Hunter